Literature DB >> 25897522

Characterization of Shigella sonnei Isolate Carrying Shiga Toxin 2-Producing Gene.

Outi Nyholm, Taru Lienemann, Jani Halkilahti, Sointu Mero, Ruska Rimhanen-Finne, Ville Lehtinen, Saara Salmenlinna, Anja Siitonen.   

Abstract

Entities:  

Keywords:  STEC; Shiga toxin 2; Shigella sonnei; bacillary dysentery; bacteria; diarrhea; shigellosis; virulence factors

Mesh:

Substances:

Year:  2015        PMID: 25897522      PMCID: PMC4412214          DOI: 10.3201/eid2105.140621

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: Shigella sonnei causes a bacillary dysentery called shigellosis. Shiga toxins 1 (Stx1) and 2 (Stx2) are mainly produced by Shiga toxin–producing Escherichia coli (STEC), but Stx1 can also be produced by S. dysenteriae serotype 1 (). Compared with STEC-producing Stx1, STEC-producing Stx2 has been reported to be more highly pathogenic and to be associated with hemolytic uremic syndrome (HUS) and hemorrhagic colitis (); the association with HUS especially has been reported for subtypes Stx2a and Stx2c (). Stx-converting bacteriophages play a key role in expression of the stx gene in E. coli and in the lateral gene transfer between the bacteria (). Although these bacteriophages have not been isolated from S. dysenteriae serotype 1, evidence suggests that the bacteria’s stx gene may be associated with a bacteriophage (). The stx gene, which is located in a bacteriophage, has previously been detected in S. sonnei (). We describe an S. sonnei isolate with the stx gene. In November 2013, 3 days after her return to Finland from a 2-week visit to relatives in southern Morocco, a 49-year-old woman was admitted to a hospital for bloody diarrhea, fever, and abdominal pain. Her symptoms began with watery diarrhea and fever 5 days before she returned home. The diarrhea ceased after a few days, but symptoms worsened, and diarrhea was visibly bloody after she returned to Finland. On admission, the patient had C-reactive protein and hemoglobin levels of 41 mg/L (reference value <3 mg/L) and 118 g/L (reference value 117–155 g/L), respectively; no thrombocytopenia was observed. No antimicrobial drugs were prescribed because STEC infection was clinically suspected. The patient responded well to intravenous fluid treatment and was discharged from the hospital 3 days after admission. At a follow-up visit 1 week later, she was asymptomatic and had a C-reactive protein level of 19 mg/L. Shigella spp. was isolated from a feces sample obtained from the patient on illness day 8, and an STEC signal (based on the PCR-positive stx gene) was detected from the same sample. A presumptive STEC strain was subsequently isolated. Both isolates were sent for confirmation and further typing to the Bacteriology Unit, National Institute for Health and Welfare, in Helsinki. The first isolate (FE109024) was confirmed as S. sonnei by matching of its biochemical profile to that of the reference strain ATCC 25931 (http://www.atcc.org/Products/All/25931.aspx; Technical Appendix Table) and agglutination by antiserum to S. sonnei (Denka Seiken, Tokyo, Japan). The agglutination by S. sonnei phase I antiserum indicated the smooth form of lipopolysaccharide. Atypical for S. sonnei, the isolate did not ferment mannitol (). The isolate carried the genes encoding invasion plasmid antigen H, the invasion-associated locus, and invasion gene transcription regulator invE. The second isolate (FE109046) was initially sent to the National Institute for Health and Welfare as an STEC. However, FE109046 showed biochemical reactions in tubes and when using API 20E (bioMérieux, Durham, NC, USA) that were identical to reactions for isolate FE109024 after an overnight and 3-day incubation (Technical Appendix Table). Both isolates were nonmotile. FE109046 also agglutinated by S. sonnei polyvalent antiserum but was negative for S. sonnei phase I antiserum and positive for phase II antiserum, indicating the rough form of lipopolysaccharide. In contrast to FE109024, isolate FE109046 lacked the Shigella/enteroinvasive E. coli–specific invE gene but harbored the STEC-specific stx gene. Neither isolate carried other STEC-associated genes. Subtyping of the stx gene of isolate FE109046 was performed according to the published protocol (); the isolate was confirmed to be subtype stx. Genomic comparison of the 2 isolates was performed by using pulsed-field gel electrophoresis according to the standard protocol. The isolates showed 96% similarity. A 3-fragment difference suggests that 1 isolate was a variant of the other (Figure); the variant may have arisen through lysogenization with the phage.
Figure

UPGMA dendrogram of XbaI restriction patterns of 2 Shigella sonnei isolates from a patient from Finland who became ill during a visit to Morocco. Genomic comparison of the 2 isolates was performed by using pulsed-field gel electrophoresis according to the standard protocol. The isolates showed 96% similarity, and a 3-fragment difference suggests that 1 isolate was a variant of the other. Scale bar represents % similarity. ial, invasion-associated locus; ipaH, invasion plasmid antigen H; invE, invasion gene transcription regulator invE; stx, Shiga toxin 2.

UPGMA dendrogram of XbaI restriction patterns of 2 Shigella sonnei isolates from a patient from Finland who became ill during a visit to Morocco. Genomic comparison of the 2 isolates was performed by using pulsed-field gel electrophoresis according to the standard protocol. The isolates showed 96% similarity, and a 3-fragment difference suggests that 1 isolate was a variant of the other. Scale bar represents % similarity. ial, invasion-associated locus; ipaH, invasion plasmid antigen H; invE, invasion gene transcription regulator invE; stx, Shiga toxin 2. The Shiga toxin subtype stx identified in isolate FE109046 is linked to severe human disease, including HUS (). The role of Stx in shigellosis is unclear. Stx is not essential for cell invasion or lysis (). In the previously reported case of stx–positive S. sonnei infection, the patient’s symptoms were not severe, and diarrhea lasted 7 days (). Shigella spp. can harbor virulence genes found in E. coli because both are genetically defined as members of the same species (). The stx–positive S. sonnei may have emerged in the patient initially infected with a mannitol-negative S. sonnei that was subsequently lysogenized by transduction from a STEC co-infection or by a free stx phage. S. sonnei isolates are not routinely examined for the production of Stx or stx genes in clinical laboratories, so the properties associated with STEC in S. sonnei isolates from patients remain undetected. S. sonnei with stx may have potential to cause severe disease, especially in children. This novel and remarkable virulence characteristic in Shigella spp. would affect diagnostics, infection control, and prevention.

Technical Appendix

Characteristics of 2 isolates from a patient compared with those of a Shigella sonnei reference strain.
  8 in total

1.  Isolation of Shigella sonnei lysogenic for a bacteriophage encoding gene for production of Shiga toxin.

Authors:  L Beutin; E Strauch; I Fischer
Journal:  Lancet       Date:  1999-05-01       Impact factor: 79.321

2.  Spontaneous tandem amplification and deletion of the shiga toxin operon in Shigella dysenteriae 1.

Authors:  M A McDonough; J R Butterton
Journal:  Mol Microbiol       Date:  1999-12       Impact factor: 3.501

3.  Variation in virulence among clades of Escherichia coli O157:H7 associated with disease outbreaks.

Authors:  Shannon D Manning; Alifiya S Motiwala; A Cody Springman; Weihong Qi; David W Lacher; Lindsey M Ouellette; Janice M Mladonicky; Patricia Somsel; James T Rudrik; Stephen E Dietrich; Wei Zhang; Bala Swaminathan; David Alland; Thomas S Whittam
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-10       Impact factor: 11.205

4.  Role of Shiga toxin in the pathogenesis of bacillary dysentery, studied by using a Tox- mutant of Shigella dysenteriae 1.

Authors:  A Fontaine; J Arondel; P J Sansonetti
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

Review 5.  Shiga-toxin-converting bacteriophages.

Authors:  H Schmidt
Journal:  Res Microbiol       Date:  2001-10       Impact factor: 3.992

Review 6.  Pathogenesis of Shiga-toxin producing escherichia coli.

Authors:  Angela Melton-Celsa; Krystle Mohawk; Louise Teel; Alison O'Brien
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

7.  Multiple independent origins of Shigella clones of Escherichia coli and convergent evolution of many of their characteristics.

Authors:  G M Pupo; R Lan; P R Reeves
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

8.  Shiga toxin 2-encoding bacteriophages in human fecal samples from healthy individuals.

Authors:  Alexandre Martinez-Castillo; Pablo Quirós; Ferran Navarro; Elisenda Miró; Maite Muniesa
Journal:  Appl Environ Microbiol       Date:  2013-06-07       Impact factor: 4.792

  8 in total
  13 in total

1.  In Silico Serotyping Based on Whole-Genome Sequencing Improves the Accuracy of Shigella Identification.

Authors:  Yun Wu; Henry K Lau; Teresa Lee; David K Lau; Justin Payne
Journal:  Appl Environ Microbiol       Date:  2019-03-22       Impact factor: 4.792

2.  Fighting Shigella by Blocking Its Disease-Causing Toxin.

Authors:  Diksha Haksar; Mostafa Asadpoor; Torben Heise; Jie Shi; Saskia Braber; Gert Folkerts; Lluis Ballell; Janneth Rodrigues; Roland J Pieters
Journal:  J Med Chem       Date:  2021-04-28       Impact factor: 7.446

3.  Shiga Toxin 1-Producing Shigella sonnei Infections, California, United States, 2014-2015.

Authors:  Katherine Lamba; Jennifer A Nelson; Akiko C Kimura; Alyssa Poe; Joan Collins; Annie S Kao; Laura Cruz; Gregory Inami; Julie Vaishampayan; Alvaro Garza; Vishnu Chaturvedi; Duc J Vugia
Journal:  Emerg Infect Dis       Date:  2016-04       Impact factor: 6.883

4.  Stx-Producing Shigella Species From Patients in Haiti: An Emerging Pathogen With the Potential for Global Spread.

Authors:  Miranda D Gray; Susan R Leonard; David W Lacher; Keith A Lampel; Meer T Alam; J Glenn Morris; Afsar Ali; Patrick T LaBreck; Anthony T Maurelli
Journal:  Open Forum Infect Dis       Date:  2015-09-19       Impact factor: 3.835

5.  Molecular Differentiation of Shigella Spp. from Enteroinvasive E. Coli.

Authors:  I Løbersli; A L Wester; Å Kristiansen; L T Brandal
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2016-08-05

6.  Recent Outbreaks of Shigellosis in California Caused by Two Distinct Populations of Shigella sonnei with either Increased Virulence or Fluoroquinolone Resistance.

Authors:  Varvara K Kozyreva; Guillaume Jospin; Alexander L Greninger; James P Watt; Jonathan A Eisen; Vishnu Chaturvedi
Journal:  mSphere       Date:  2016-12-21       Impact factor: 4.389

7.  A Novel Shiga Toxin 1a-Converting Bacteriophage of Shigella sonnei With Close Relationship to Shiga Toxin 2-Converting Pages of Escherichia coli.

Authors:  Christoph C Carter; Joshua Fierer; Wei Wei Chiu; David J Looney; Matthew Strain; Sanjay R Mehta
Journal:  Open Forum Infect Dis       Date:  2016-04-19       Impact factor: 3.835

8.  Comparative Genomic and Phylogenetic Analysis of a Shiga Toxin Producing Shigella sonnei (STSS) Strain.

Authors:  Domonkos Sváb; Balázs Bálint; Bálint Vásárhelyi; Gergely Maróti; István Tóth
Journal:  Front Cell Infect Microbiol       Date:  2017-05-30       Impact factor: 5.293

9.  Shigella sonnei and hemolytic uremic syndrome: A case report and literature review.

Authors:  Casey Adams; Aaron Vose; Michael B Edmond; Laurel Lyckholm
Journal:  IDCases       Date:  2017-02-10

10.  Closed Genome and Comparative Phylogenetic Analysis of the Clinical Multidrug Resistant Shigella sonnei Strain 866.

Authors:  Anna Allué-Guardia; Sara S K Koenig; Pablo Quirós; Maite Muniesa; James L Bono; Mark Eppinger
Journal:  Genome Biol Evol       Date:  2018-09-01       Impact factor: 3.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.